BridgeMD
Compares treatment options for Catheter Complications
Official title Heparinization vs Salinization of the Peripheral Venous Catheter
ClinicalTrials.gov ID: NCT05209841
What this study is testing
What is Low dose heparin?
Low dose heparin is an investigational medicine, being studied as a potential treatment for catheter complications.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Randomized, double-blind clinical trial to compare the efficacy of catheter sealing with saline, compared to low-dose heparin. 3,450 patients hospitalized at the Hospital Residencia Sant Camil, in Catalonia (Spain), will be randomized to each branch of study.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Patients older than 18 yo, admitted to the Hospital Residencia Sant Camil
- Patients with at least one peripheral venous line for discontinuous treatment, which has not been channeled in a medical emergency situation.
- Written informed consent
You likely can't join if
- Allergy to heparin
- Patients treated with unfractionated sodium heparin.
- Patients in dialysis
- Patients with a venous catheter indicated for diagnosis tests.
- Patients with a venous catheter indicated for blood transfusion
- Severe heparin-induced thrombocytopenia in recent months
See the full eligibility criteria
- Patients older than 18 yo, admitted to the Hospital Residencia Sant Camil
- Patients with at least one peripheral venous line for discontinuous treatment, which has not been channeled in a medical emergency situation.
- Written informed consent
- Allergy to heparin
- Patients treated with unfractionated sodium heparin.
- Patients in dialysis
- Patients with a venous catheter indicated for diagnosis tests.
- Patients with a venous catheter indicated for blood transfusion
- Severe heparin-induced thrombocytopenia in recent months
- Active uncontrollable bleeding during admission
- Brain aneurysm or dissecting aorta, except in association with corrective surgery.
- Confirmed / suspected cerebrovascular hemorrhage
- Severe uncontrolled hypertension
- Severe alterations in platelet coagulation \ 1.7 APTT ratio\> 1.7 ratio.
- Patient included in another clinical trial with drugs or procedures that may affect the patency of venous catheters.
The study team makes the final eligibility decision.
Where it's taking place
- Sant Pere de Ribes, Barcelona, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sant Pere de Ribes, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.